Guest
Signals accepts guest blog posts on topics relevant to stem cells and regenerative medicine, as well as submissions for its Right Turn Friday feature. The opinions, accuracy, completeness and validity of any statements made in guest posts are the responsibility of the author only and not the editor of Signals or CCRM, publisher of Signals. The copyright of this content belongs to the author and any liability with regards to infringement of intellectual property rights remains with the author. To reach the publisher, email info(at)CCRM.ca
Posts by: Guest
Navigating the regulatory complexity of regenerative medicine in Canada
Siofradh McMahon is Senior Manager, Clinical Translation and Regulatory Affairs at CCRM. Síofradh works with academic and industry partners to advance promising products and technologies to commercialization. Having worked worldwide, Síofradh brings more than a decade of experience in pharmaceutical and biotech regulatory affairs and policy. She is an active member of the Alliance for […]
Meet Dr. Heidi Gardner: the force behind Science On A Postcard
Farah Qaiser is a graduate student at the University of Toronto, where her research involves whole-genome sequencing of patients with neurological disorders. When not in the lab, Farah dabbles in various science communication, policy and outreach initiatives. You can find Farah live-tweeting Toronto’s many science events at @this_is_farah or speed-reading (yet another) dystopian novel on her commute home. In early January, Toronto played host […]
CCRM’s inaugural investor symposium: Recap and key takeaways
Matthew Mistry is a Market and Equity Analyst at CCRM, where he conducts investment diligence, market analyses, participates in company creation activities and supports strategic business development. He joined CCRM from the Ontario Bioscience Innovation Organization (OBIO) where he was involved in supporting health science companies gain access to private and public capital, providing strategic […]